Complete financial analysis of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- GFA Co., Ltd. (8783.T) Income Statement Analysis – Financial Results
- Silverlake Axis Ltd (SLVFF) Income Statement Analysis – Financial Results
- Apex International Co., Ltd. (4927.TW) Income Statement Analysis – Financial Results
- Metalink Ltd. (MTLK) Income Statement Analysis – Financial Results
- Littelfuse, Inc. (LFUS) Income Statement Analysis – Financial Results
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ)
About Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. engages in the manufacture and sale of medical devices in China and internationally. The company offers respiratory therapy solutions, including ventilator, humidifier, oxygen generator, and atomizer, as well as non-invasive ventilator data management system; chronic disease monitoring systems, such as sphygmomanometer, blood glucose meter, blood oxygen monitoring, blood temperature detection, stethoscope, as well as general practice diagnostic and in-hospital blood glucose management platform. It also provides imaging diagnosis and treatment solutions, which include ultrasound diagnostic imaging, and intervention and minimally invasive solutions; infection control and disinfection products; and ophthalmology and vision care products comprising microscope, eye surgery instrument, ophthalmoscope, synoptograph, and keratometer; and defibrillator monitors. In addition, the company offers durable equipment and consumables consisting of basic surgery, microsurgery, five sense organs, orthopedic tools and equipment, endoscopic, kiss combiner, dental appliance, acupuncture, electronic acupuncture, absorbable suture, and venous indwelling needle puncture products. The company was formerly known as Yuwell medical. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was founded in 1998 and is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.97B | 7.10B | 6.89B | 6.73B | 4.64B | 4.18B | 3.54B | 2.63B | 2.10B | 1.68B | 1.42B | 1.31B | 1.17B | 883.90M | 537.88M | 401.37M | 289.48M | 231.99M | 212.53M |
| Cost of Revenue | 3.87B | 3.68B | 3.57B | 3.18B | 2.68B | 2.52B | 2.14B | 1.61B | 1.27B | 1.01B | 887.45M | 822.93M | 754.85M | 572.38M | 332.65M | 283.47M | 202.03M | 163.86M | 153.76M |
| Gross Profit | 4.10B | 3.42B | 3.33B | 3.54B | 1.96B | 1.67B | 1.40B | 1.02B | 837.72M | 672.39M | 536.87M | 489.28M | 415.66M | 311.52M | 205.23M | 117.90M | 87.45M | 68.13M | 58.78M |
| Gross Profit Ratio | 51.49% | 48.13% | 48.29% | 52.68% | 42.21% | 39.83% | 39.66% | 38.69% | 39.82% | 39.98% | 37.69% | 37.29% | 35.51% | 35.24% | 38.16% | 29.37% | 30.21% | 29.37% | 27.66% |
| Research & Development | 504.37M | 496.40M | 425.67M | 401.52M | 235.07M | 152.12M | 125.74M | 120.09M | 151.39M | 141.75M | 76.75M | 71.08M | 55.87M | 36.34M | 23.26M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 114.51M | 111.94M | 132.69M | 137.44M | 94.74M | 98.42M | 94.32M | 57.11M | 60.76M | 29.74M | 33.64M | 25.03M | 23.85M | 18.31M | 12.95M | 22.70M | 18.35M | 14.20M | 9.97M |
| Selling & Marketing | 730.57M | 1.03B | 945.01M | 754.06M | 630.09M | 536.80M | 399.77M | 202.79M | 169.31M | 148.44M | 123.97M | 96.22M | 83.52M | 53.68M | 34.10M | 17.30M | 10.65M | 7.42M | 7.72M |
| SG&A | 845.08M | 1.14B | 1.08B | 891.51M | 724.82M | 635.23M | 494.08M | 259.90M | 230.07M | 178.18M | 157.62M | 121.25M | 107.38M | 71.98M | 47.05M | 40.00M | 29.00M | 21.62M | 17.68M |
| Other Expenses | -138.08M | 217.92M | 216.81M | 211.88M | 164.24M | 69.69M | 37.22M | 32.41M | 33.25M | 50.01M | 46.84M | 18.52M | 41.99M | 10.63M | 4.22M | -1.30M | 6.99M | 12.25M | 64.92M |
| Operating Expenses | 1.17B | 1.86B | 1.72B | 1.50B | 1.12B | 941.97M | 748.55M | 509.40M | 457.54M | 377.42M | 279.23M | 229.74M | 198.79M | 134.38M | 89.77M | 42.34M | 30.90M | 23.09M | 18.23M |
| Cost & Expenses | 5.08B | 5.54B | 5.29B | 4.69B | 3.80B | 3.46B | 2.89B | 2.12B | 1.72B | 1.39B | 1.17B | 1.05B | 953.65M | 706.77M | 422.43M | 325.81M | 232.94M | 186.95M | 171.98M |
| Interest Income | 214.76M | 56.06M | 40.96M | 26.00M | 11.99M | 9.67M | 10.89M | 9.29M | 2.44M | 5.10M | 4.66M | 7.49M | 4.55M | 539.24K | 1.44M | 2.85M | 291.21K | 372.57K | 137.34K |
| Interest Expense | 58.55M | 57.74M | 30.49M | 15.25M | 8.19M | 3.58M | 5.43M | 7.37M | 11.57M | 2.51M | 255.57K | 321.98K | 361.37K | 2.27M | 1.68M | 2.82M | 5.29M | 3.10M | 1.24M |
| Depreciation & Amortization | 254.81M | 254.63M | 237.95M | 213.99M | 117.00M | 103.99M | 86.13M | 69.42M | 52.42M | 36.14M | 29.43M | 27.03M | 23.26M | 19.60M | 12.75M | 8.56M | 6.48M | 4.35M | 3.17M |
| EBITDA | 3.15B | 2.14B | 1.96B | 2.17B | 890.70M | 940.12M | 805.87M | 650.30M | 471.79M | 372.34M | 332.81M | 308.98M | 287.34M | 202.50M | 133.93M | 85.04M | 69.24M | 60.92M | 107.08M |
| EBITDA Ratio | 39.55% | 29.09% | 28.72% | 33.04% | 21.26% | 22.81% | 23.05% | 24.75% | 22.67% | 23.01% | 23.54% | 23.86% | 24.44% | 23.61% | 25.05% | 21.28% | 24.37% | 26.54% | 51.01% |
| Operating Income | 2.89B | 1.84B | 1.69B | 2.01B | 849.89M | 776.20M | 682.98M | 540.64M | 375.41M | 284.87M | 252.60M | 260.55M | 218.50M | 171.05M | 113.90M | 74.97M | 50.47M | 41.45M | 37.74M |
| Operating Income Ratio | 36.30% | 25.93% | 24.48% | 29.88% | 18.33% | 18.55% | 19.28% | 20.54% | 17.84% | 16.94% | 17.73% | 19.86% | 18.67% | 19.35% | 21.18% | 18.68% | 17.44% | 17.87% | 17.76% |
| Total Other Income/Expenses | -44.66M | 614.23K | 13.80M | 8.98M | 14.46M | 69.69M | 37.22M | 31.08M | 33.11M | 48.83M | 45.55M | 16.58M | 41.96M | 9.57M | 3.97M | -1.30M | 6.99M | 12.02M | 64.92M |
| Income Before Tax | 2.85B | 1.84B | 1.70B | 2.02B | 864.34M | 845.89M | 720.20M | 572.51M | 407.80M | 333.69M | 298.15M | 278.99M | 260.46M | 180.62M | 118.11M | 73.67M | 57.47M | 53.47M | 102.66M |
| Income Before Tax Ratio | 35.74% | 25.94% | 24.68% | 30.01% | 18.64% | 20.22% | 20.34% | 21.75% | 19.38% | 19.84% | 20.93% | 21.26% | 22.25% | 20.43% | 21.96% | 18.35% | 19.85% | 23.05% | 48.31% |
| Income Tax Expense | 472.36M | 269.73M | 217.82M | 262.04M | 102.77M | 95.00M | 92.66M | 70.93M | 41.12M | 35.80M | 39.59M | 33.92M | 32.60M | 19.30M | 16.97M | 11.65M | 18.97M | 23.50M | 19.36M |
| Net Income | 2.40B | 1.60B | 1.48B | 1.76B | 752.57M | 727.15M | 592.03M | 500.26M | 364.34M | 297.00M | 258.05M | 244.10M | 226.41M | 160.88M | 100.54M | 61.83M | 37.87M | 31.55M | 58.77M |
| Net Income Ratio | 30.05% | 22.46% | 21.50% | 26.15% | 16.23% | 17.38% | 16.72% | 19.00% | 17.32% | 17.66% | 18.12% | 18.60% | 19.34% | 18.20% | 18.69% | 15.41% | 13.08% | 13.60% | 27.65% |
| EPS | 2.39 | 1.61 | 1.49 | 1.75 | 0.75 | 0.73 | 0.59 | 0.53 | 0.41 | 0.34 | 0.30 | 0.28 | 0.33 | 0.19 | 0.12 | 0.08 | 0.07 | 0.08 | 0.14 |
| EPS Diluted | 2.39 | 1.61 | 1.49 | 1.75 | 0.75 | 0.73 | 0.59 | 0.53 | 0.41 | 0.34 | 0.30 | 0.28 | 0.33 | 0.19 | 0.12 | 0.08 | 0.07 | 0.08 | 0.14 |
| Weighted Avg Shares Out | 1.00B | 990.71M | 994.91M | 1.00B | 1.00B | 996.10M | 1.00B | 943.06M | 881.48M | 873.54M | 868.87M | 875.58M | 679.24M | 862.73M | 841.61M | 789.61M | 577.69M | 1.00B | 1.00B |
| Weighted Avg Shares Out (Dil) | 1.00B | 990.71M | 994.91M | 1.00B | 1.00B | 996.10M | 1.00B | 943.06M | 881.48M | 873.54M | 868.96M | 875.58M | 679.24M | 862.73M | 841.61M | 789.61M | 577.69M | 1.00B | 1.00B |
Source: https://incomestatements.info
Category: Stock Reports